 Connection
Christina Aquilante to Dihydrouracil Dehydrogenase (NADP)
This is a "connection" page, showing publications Christina Aquilante has written about Dihydrouracil Dehydrogenase (NADP).
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.673 |
|
|
|
-
El Rouby N, Aquilante CL, Bargal SA, Cavallari LH, Duarte JD, Gunderson K, Mazhindu T, Nagy M, Nie X, Nguyen DG, Patel JN, Skaar TC, Smith DM, Tuteja S, van Schaik RHN, Hicks JK. Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine Therapy. Clin Transl Sci. 2026 01; 19(1):e70466.
Score: 0.237
-
Ho TT, Smith DM, Aquilante CL, Cicali EJ, El Rouby N, Hertz DL, Imanirad I, Patel JN, Scott SA, Swain SM, Tuteja S, Hicks JK. A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice. Clin Pharmacol Ther. 2025 May; 117(5):1194-1208.
Score: 0.222
-
Tracksdorf T, Smith DM, Pearse S, Cicali EJ, Aquilante CL, Scott SA, Ho TT, Patel JN, Hicks JK, Hertz DL. Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US. Support Care Cancer. 2024 Jul 09; 32(8):497.
Score: 0.214
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|